-
FDA approves new cancer drug
SAN FRANCISCO — The Food and Drug Administration has approved a new drug for colorectal cancer developed by Bayer HealthCare.
Bayer and Onyx Pharmaceuticals announced the approval of Stivarga for colorectal cancer that has spread to other parts of the body, also known as metastatic CRC, specifically for those patients who have received treatment with currently available therapies.
Bayer developed the drug and will pay royalties to Onyx on future global net sales of the drug for cancer. The two companies will promote the drug together in the United States.
-
Celestial Seasonings' Enerji shots give consumers a jolt with green tea
BOULDER, Colo. — Celestial Seasonings has launched a line of single-serve and shelf-stable energy shots.
Enerji shots combine naturally energizing green tea with a blend of B vitamins and ginseng and do not contain artificial flavors, colors, sweeteners or preservatives. The new shots are packaged in convenient 2.5-fl.-oz. bottles and are available in three flavor varieties: citrus, berry and Pomegranate Xtreme (with more caffeine and B-vitamins than regular Enerji shots).